Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Pang Chang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|March 3, 2016
Type VI adenylyl cyclase negatively regulates GluN2B-mediated LTD and spatial reversal learningChing-Pang Chang, Cheng-Ta Lee, Wen-Hsien Hou, et al.
Neurobiology of Disease|August 29, 2016
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington diseaseXavier Guitart, Jordi Bonaventura, William Rea, et al.
Journal of Cellular Physiology|February 10, 2010
Non-genomic rapid inhibition of Na+/H+-exchange 1 and apoptotic immunosuppression in human T cells by glucocorticoidsChing-Pang Chang, Shyi-Wu Wang, Zih-Ling Huang, et al.
Cell Reports|October 9, 2025
Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivityYa-Gin Chang, Hsin-Chuan Lin, Ching-Pang Chang, et al.
The Journal of Cell Biology|July 20, 2011
Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's diseaseTz-Chuen Ju, Hui-Mei Chen, Jiun-Tsai Lin, et al.
Molecular Neurobiology|April 5, 2018
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's DiseaseChia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, et al.
Nature Communications|August 4, 2019
Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's diseaseJian Jing Siew, Hui-Mei Chen, Huan-Yuan Chen, et al.
Human Molecular Genetics|July 30, 2010
Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gammaMing-Chang Chiang, Chiung-Mei Chen, Maw-Rong Lee, et al.
Plos One|November 20, 2009
Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalusMing-Jen Lee, Ching-Pang Chang, Yi-Hsin Lee, et al.
Acta Neuropathologica Communications|June 23, 2021
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathyChing-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|March 3, 2016
Type VI adenylyl cyclase negatively regulates GluN2B-mediated LTD and spatial reversal learningChing-Pang Chang, Cheng-Ta Lee, Wen-Hsien Hou, et al.
Neurobiology of Disease|August 29, 2016
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington diseaseXavier Guitart, Jordi Bonaventura, William Rea, et al.
Journal of Cellular Physiology|February 10, 2010
Non-genomic rapid inhibition of Na+/H+-exchange 1 and apoptotic immunosuppression in human T cells by glucocorticoidsChing-Pang Chang, Shyi-Wu Wang, Zih-Ling Huang, et al.
Cell Reports|October 9, 2025
Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivityYa-Gin Chang, Hsin-Chuan Lin, Ching-Pang Chang, et al.
The Journal of Cell Biology|July 20, 2011
Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's diseaseTz-Chuen Ju, Hui-Mei Chen, Jiun-Tsai Lin, et al.
Molecular Neurobiology|April 5, 2018
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's DiseaseChia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, et al.
Nature Communications|August 4, 2019
Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's diseaseJian Jing Siew, Hui-Mei Chen, Huan-Yuan Chen, et al.
Human Molecular Genetics|July 30, 2010
Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gammaMing-Chang Chiang, Chiung-Mei Chen, Maw-Rong Lee, et al.
Plos One|November 20, 2009
Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalusMing-Jen Lee, Ching-Pang Chang, Yi-Hsin Lee, et al.
Acta Neuropathologica Communications|June 23, 2021
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathyChing-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, et al.
Pageof 2